Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
benzodiazepine
sedative |
| gptkbp:ATCCode |
N05CA01
|
| gptkbp:CASNumber |
76-74-4
|
| gptkbp:chemicalFormula |
C11H18N2O3
|
| gptkbp:discoveredIn |
1930
|
| gptkbp:eliminationHalfLife |
15-48 hours
|
| gptkbp:hasPotentialForAbuse |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
pentobarbitone
|
| gptkbp:isApprovedDrug |
yes
|
| gptkbp:legalStatus |
controlled substance
|
| gptkbp:mechanismOfAction |
GABA-A receptor agonist
|
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
226.27 g/mol
|
| gptkbp:otherName |
gptkb:Nembutal
gptkb:pentobarbital |
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:routeOfAdministration |
oral
intramuscular intravenous |
| gptkbp:sideEffect |
drowsiness
hypotension respiratory depression |
| gptkbp:usedFor |
euthanasia
anesthesia seizure control |
| gptkbp:usedInVeterinaryMedicine |
yes
|
| gptkbp:bfsParent |
gptkb:Pentobarbital
gptkb:pentobarbital |
| gptkbp:bfsLayer |
7
|